湿疹治療薬の世界市場:市場インサイト、疫学、市場予測

◆英語タイトル:Eczema - Market Insights, Epidemiology and Market Forecast-2023
◆商品コード:DLVEP06064
◆発行会社(調査会社):DelveInsight
◆発行日:2016年9月
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後10営業日)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名使用)USD4,950 ⇒換算¥549,450見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD9,900 ⇒換算¥1,098,900見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD14,850 ⇒換算¥1,648,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規販売代理店です。DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、湿疹治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。
・湿疹の概要
・病態生理
・湿疹の症状
・湿疹の病因
・湿疹の診断
・湿疹の治療
・上市品の概要
・医薬品の説明
・作用機序
・薬物動態学的特性
・特許情報
・湿疹の疫学分析
・湿疹治療薬の世界市場規模
・湿疹治療薬の世界市場予測
・湿疹治療薬のアメリカ市場規模
・湿疹治療薬のアメリカ市場予測
・湿疹治療薬のヨーロッパ市場規模
・湿疹治療薬のヨーロッパ市場予測
(ドイツ、イギリス、フランス、イタリア、スペイン)
・湿疹治療薬の日本市場規模
・湿疹治療薬の日本市場予測
【レポートの概要】

Note*: This report requires 7-10 business days to complete.

DelveInsight’s Eczema – Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Eczema forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Eczema till 2023.

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Eczema market.
• Identifying patient populations in the global “Eczemamarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Eczema therapeutics in each of the markets covered.
• To understand the future market competition in the global Eczema therapeutics market and Insightful review of the key market drivers and barriers.

Scope

• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Eczema for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

【レポートの目次】

Table of Contents

• Eczema overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Eczema Market
• Global Epidemiology of Eczema Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight

List of Tables

• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Eczema Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Eczema (2013-2023)
• Table 7: Eczema Global Market (USD Millions), (2013-2015)
• Table 8: Eczema Global Market (USD Millions), (2016-2023)
• Table 9: Eczema US Market (USD Millions), (2013-2015)
• Table 10: Eczema US Market (USD Millions), (2016-2023)
• Table 11: Eczema Germany Market (USD Millions), (2013-2015)
• Table 12: Eczema Germany Market (USD Millions), (2016-2023)
• Table 13: Eczema United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Eczema United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Eczema France Market (USD Millions), (2013-2015)
• Table 16: Eczema France Market (USD Millions), (2016-2023)
• Table 17: Eczema Italy Market (USD Millions), (2013-2015)
• Table 18: Eczema Italy Market (USD Millions), (2016-2023)
• Table 19: Eczema Spain Market (USD Millions), (2013-2015)
• Table 20: Eczema Spain Market (USD Millions), (2016-2023)
• Table 21: Eczema Japan Market (USD Millions), (2013-2015)
• Table 22: Eczema Japan Market (USD Millions), (2016-2023)
• Table 23: Eczema ROW Market (USD Millions), (2013-2015)
• Table 24: Eczema ROW Market (USD Millions), (2016-2023)

List of Figures

• Figure 1: Eczema Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Eczema (2013-2023)
• Figure 3: Eczema Global Market (USD Millions), (2013-2015)
• Figure 4: Eczema Global Market (USD Millions), (2016-2023)
• Figure 5: Eczema US Market (USD Millions), (2013-2015)
• Figure 6: Eczema US Market (USD Millions), (2016-2023)
• Figure 7: Eczema Germany Market (USD Millions), (2013-2015)
• Figure 8: Eczema Germany Market (USD Millions), (2016-2023)
• Figure 9: Eczema United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Eczema United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Eczema France Market (USD Millions), (2013-2015)
• Figure 12: Eczema France Market (USD Millions), (2016-2023)
• Figure 13: Eczema Italy Market (USD Millions), (2013-2015)
• Figure 14: Eczema Italy Market (USD Millions), (2016-2023)
• Figure 15: Eczema Spain Market (USD Millions), (2013-2015)
• Figure 16: Eczema Spain Market (USD Millions), (2016-2023)
• Figure 17: Eczema Japan Market (USD Millions), (2013-2015)
• Figure 18: Eczema Japan Market (USD Millions), (2015-2023)
• Figure 19: Eczema ROW Market (USD Millions), (2013-2015)
• Figure 20: Eczema ROW Market (USD Millions), (2016-2023)



【掲載企業】

• Novartis AG
• GlaxoSmithKline Plc
• Astellas Pharma Inc.
• Sanofi
• Regeneron Pharmaceuticals Inc.
• The LEO Foundation
• Bayer AG
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd.
• Anacor Pharmaceuticals Inc.


【レポートのキーワード】

湿疹

★調査レポート[湿疹治療薬の世界市場:市場インサイト、疫学、市場予測]販売に関する免責事項
★調査レポート[湿疹治療薬の世界市場:市場インサイト、疫学、市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆